Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |